Medical News

RSS

HEI's first-quarter 2010 net sales increase to $9,520,000

HEI, Inc. today announced its financial results for its first quarter of fiscal year 2010, which ended April 3, 2010.

26 Apr 2010

GlowCaps receives 2010 Medical Design Excellence Award for innovative design

Vitality, Inc., developer of GlowCaps, Internet-connected pill bottle caps, announced today that GlowCaps has received a 2010 Medical Design Excellence Award, for innovative product design.

26 Apr 2010

Exercise helps retain greater bone density: Researchers

The stage for osteoporosis is set well before menopause-but exercise can help rewrite the script, according to Medical College of Georgia researchers.

26 Apr 2010

EDAP announces strategy for ongoing U.S. ENLIGHT Ablatherm-HIFU clinical trial

EDAP TMS SA, the global leader in therapeutic ultrasound, today announced its strategy for the ongoing U.S. ENLIGHT Ablatherm-HIFU clinical trial. Following the FDA Gastroenterology and Urology Devices Panel in December 2009 and the Company's January 2010 meeting with the FDA concerning its recommendations for the trial protocol, the Company has thoroughly evaluated all options aiming at an IDE submission in a feasible timeframe and with acceptable economics.

26 Apr 2010

The Frost Group agrees to make investment in ChromaDex

ChromaDex Corporation, a natural products chemistry company which provides novel and innovative ingredients to the dietary supplement, food, beverage and cosmetic markets, announced today The Frost Group, LLC, led by Miami entrepreneur and billionaire Dr. Phillip Frost, has agreed to make an investment in ChromaDex.

26 Apr 2010

Caltech biologists offer new insight into causes of IBD and colon cancer

We are not alone-even in our own bodies. The human gut is home to 100 trillion bacteria, which, for millions of years, have co-evolved along with our digestive and immune systems. Most people view bacteria as harmful pathogens that cause infections and disease. Other, more agreeable, microbes (known as symbionts) have taken a different evolutionary path, and have established beneficial relationships with their hosts.

26 Apr 2010

Aton Pharma acquires the U.S. marketing rights to LODOSYN tablets from BMS

Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has acquired the U.S. marketing rights to LODOSYN (carbidopa) tablets from Bristol-Myers Squibb Company.

26 Apr 2010

OSI Pharmaceuticals completes enrollment in Phase III clinical trial of Tarceva

OSI Pharmaceuticals, Inc. announced today that it has completed enrollment in the RADIANT study, a Phase III clinical trial testing Tarceva (erlotinib) as an adjuvant therapy in patients with Stage IB-IIIA non-small cell lung cancer who have undergone surgery and have EGFR-positive tumors.

26 Apr 2010

American board-certified prosthetist develops custom-made ankle-foot orthosis

With over ten million diabetics in the U.S. alone and approximately 150,000 amputations performed yearly, inventor and American board-certified prosthetist John E. Rooney developed a custom-made ankle-foot orthosis with the trade name Ulcer Healing Orthosis or UHO.

26 Apr 2010

CompCare launches behavioral health services for a health plan in Texas

Comprehensive Care Corporation today announced the launching of its behavioral health services for a health plan in Texas.

26 Apr 2010

Novartis exercises current right to purchase 55,223 unregistered shares of Alnylam's common stock

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that Novartis has elected to fully exercise its current right to purchase 55,223 unregistered shares of Alnylam's common stock in accordance with the terms of the Investor Rights Agreement between Alnylam and Novartis, dated September 6, 2005.

26 Apr 2010

First patient enrolled in Phase II clinical trial of E10030 for treatment of wet age-related AMD

Ophthotech Corp., a privately held biopharmaceutical company focused on developing ophthalmic therapies for back-of-the-eye diseases, today announced that the first patient has been enrolled in its Phase II randomized, controlled clinical trial of E10030, an anti-PDGF aptamer, in combination with Lucentis® for the treatment of wet age-related macular degeneration (AMD).

26 Apr 2010

New FDA approved Landon Medical PC-60C2 Finger Pulse Oximeter introduced for home use

PulseOximetersDIRECT.com, the leading online retailer of portable Pulse Oximeter products introduces today the new FDA approved Landon Medical PC-60C2 Finger Pulse Oximeter for home use.

26 Apr 2010

Phase 1/2 clinical trial of TRC105 therapy initiated for patients with castrate-resistant prostate cancer

TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and ophthalmology, announced today that the National Cancer Institute has initiated a Phase 1/2 clinical trial of TRC105 therapy for patients with castrate-resistant prostate cancer.

26 Apr 2010

Cytovance Biologics, Selexys Pharmaceutical announce collaboration for Anti-PSGL-1 therapeutic agent

Cytovance Biologics, LLC and Selexys Pharmaceutical Corporation jointly announce an agreement and execution of a Biopharmaceutical Development and Manufacturing collaboration for their Anti-PSGL-1 therapeutic agent. This monoclonal antibody (mAb) is being developed for treatment of inflammation associated with Crohn's disease as a lead indication.

26 Apr 2010

Duke University Medical Center installs Veran Medical Technologies' SPiN Drive system

Veran Medical Technologies announced today that it has recently completed its first installation and performed several procedures at Duke University Medical Center with its FDA-cleared SPiN Drive product. The product enables clinicians to navigate deep into the peripheral regions of the lungs to access, biopsy and treat potentially cancerous Solitary Pulmonary Nodules.

26 Apr 2010

BG Medicine, Inverness Medical Innovations enter agreement for galectin-3 test for Triage Meter Pro

BG Medicine, Inc. announced today that it has entered into an agreement with Inverness Medical Innovations, Inc.—a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management—for the development and commercialization of a galectin-3 test for Inverness' Triage® Meter Pro®. Galectin-3 is a novel biomarker that may play a role in detecting the development and progression of heart failure.

26 Apr 2010

Bayer Diabetes Care launches DIDGET blood glucose monitoring system in the US

Bayer Diabetes Care today announced the introduction of the DIDGET™ blood glucose monitoring system in the United States. The DIDGET meter is unique because it is the only blood glucose meter that connects directly to Nintendo DS™ and DS Lite gaming systems to help kids manage a lifelong disease by rewarding them for building consistent testing habits and meeting personalized blood glucose target ranges. Bayer's DIDGET meter is now available for purchase in the U.S. through CVS.com, Drugstore.com and Walgreens.com.

26 Apr 2010

Thoratec to sell ITC division to Danaher

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it has signed a definitive agreement to sell its International Technidyne Corporation (ITC) division to Danaher Corporation ( DHR).

From Danaher 26 Apr 2010

Grape-enriched diet prevents risk factors for metabolic syndrome: Researchers

Scientists at the University of Michigan Health System are teasing out clues to the effect of grapes in reducing risk factors related to cardiovascular disease and metabolic syndrome. The effect is thought to be due to phytochemicals -- naturally occurring antioxidants - that grapes contain.

26 Apr 2010

Medical News

HEI's first-quarter 2010 net sales increase to $9,520,000

GlowCaps receives 2010 Medical Design Excellence Award for innovative design

Exercise helps retain greater bone density: Researchers

EDAP announces strategy for ongoing U.S. ENLIGHT Ablatherm-HIFU clinical trial

The Frost Group agrees to make investment in ChromaDex

Caltech biologists offer new insight into causes of IBD and colon cancer

Aton Pharma acquires the U.S. marketing rights to LODOSYN tablets from BMS

OSI Pharmaceuticals completes enrollment in Phase III clinical trial of Tarceva

American board-certified prosthetist develops custom-made ankle-foot orthosis

CompCare launches behavioral health services for a health plan in Texas

Novartis exercises current right to purchase 55,223 unregistered shares of Alnylam's common stock

First patient enrolled in Phase II clinical trial of E10030 for treatment of wet age-related AMD

New FDA approved Landon Medical PC-60C2 Finger Pulse Oximeter introduced for home use

Phase 1/2 clinical trial of TRC105 therapy initiated for patients with castrate-resistant prostate cancer

Cytovance Biologics, Selexys Pharmaceutical announce collaboration for Anti-PSGL-1 therapeutic agent

Duke University Medical Center installs Veran Medical Technologies' SPiN Drive system

BG Medicine, Inverness Medical Innovations enter agreement for galectin-3 test for Triage Meter Pro

Bayer Diabetes Care launches DIDGET blood glucose monitoring system in the US

Thoratec to sell ITC division to Danaher

Grape-enriched diet prevents risk factors for metabolic syndrome: Researchers

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News